Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna
2024-01-11 21:20:04
评论|
Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna
2024-01-11 21:20:04
评论|
点击排行
- Murray Energy Corporation宣布在Mission Coal破
- SES Swaps SES-12 and SES-14 Launches
- New Analyses from Pivotal Phase III Trials of
- The 3rd Myanmar Textile Summit 2019
- Rimini Street Extends Its Award-Winning Suppor
- Janssen’s New Darunavir-Based Single Tablet R
- EMQ Expands Global Payment Capabilities into S
- Amazon Announces 71 New Renewable Energy Proje
- 全球投资者法律顾问ROSEN鼓励损失超过10万美元的
- Michelob ULTRA Becomes NBA’s First-ever Globa
推荐文章
- Kioxia扩展第八代BiCS FLASH SSD产品组合,推出高性
- SLB宣布召开2025年第二季度业绩电话会议
- 科威特在2025年大阪世博会举办国庆日庆典,震撼展示
- 科兴董事会胜诉,纽约法院驳回尚珹资本/Prime 诉讼
- TH Global Capital 连续第三年荣膺第16届年度国际
- NEL动物心脏医疗中心成功完成全球首例犬类复杂室
- Prime Success发表声明纽约州法院认可我们作为科
- “立足STCO集成系统设计” 芯和半导体在DAC上发布
- Yokogawa攜手Shell,共同推動機器人與AI技術在工廠
- SAIF Partners提交Sinovac Biotech 2025年特别股